CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 20 enrolled
Drug / intervention
hepatobiliary scintigraphyprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02846441
NCT02846441N/ACompleted

Interstage Assessment of Remnant Liver Function in ALPPS: Can SPECT Hepatobiliary Scintigraphy Provide Any Additional Value in Predicting Risk of Posthepatectomy Liver Failure?

Hospital Italiano de Buenos Aires·observational·Posted Jul 27, 2016·Updated Jul 28, 2016

In Brief

An observational study evaluating hepatobiliary scintigraphy for Liver Failure. Completed, enrolled 20 participants across 1 site.

Detailed Summary

Post-hepatectomy liver failure is one of the most feared complications by hepatic surgeons. When size of the future liver remnant (FLR) is regarded to be not sufficient to sustain post-hepatectomy liver function, techniques as preoperative portal vein embolization or two-stage hepatectomy/associating liver partition and portal vein ligation (ALPPS) can be performed. ALPPS induces rapid and extensive hypertrophy by portal vein ligation and in situ liver splitting. To date, feasibility of the second stage of ALPPS has been assessed only on the basis of standardized future liver remnant or future liver remnant on body weight. However, decrease of liver function between stages, measured by means of laboratory parameters, has been demonstrated to be associated with higher 90-day mortality, regardless of FLR volume. In other words, this volumetric increase may not reflect the increase of liver function.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsLiver Failure
CountriesArgentina
Collaborators--

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedJul 27, 2016
Enrollment StartJul 1, 2011
Primary CompletionMar 1, 2016
Study CompletionJun 1, 2016
TodayJul 2, 2026
Enrollment to primary: 4.7 yearsPosted 9.9 years ago

Interventions

hepatobiliary scintigraphyprocedure

99mTc-mebrofenin hepatobiliary scintigraphy with single photon emission computed tomography (SPECT)